Moran Susan 4
4 · Tyra Biosciences, Inc. · Filed Jun 1, 2026
Research Summary
AI-generated summary of this filing
Tyra Biosciences (TYRA) Director Susan Moran Receives Option Award
What Happened
Susan Moran, a director of Tyra Biosciences (TYRA), was granted a derivative award (option) covering 13,160 shares on May 28, 2026. The Form 4 reports the acquisition price as $0.00 (an award/grant); no cash purchase or sale was reported.
Key Details
- Transaction date: 2026-05-28 (reported on Form 4 filed 2026-06-01). Transaction code: A (award/grant), derivative transaction.
- Shares/options granted: 13,160; acquisition price shown as $0.00 (award). Filing reports the grant as a derivative instrument.
- Shares owned after transaction: not disclosed in the filing.
- Footnote: Grant made under the Issuer's Non-Employee Director Compensation Program. Vesting: 1/12th of the option vests monthly beginning May 28, 2026; if the next annual meeting occurs before the first anniversary, any remaining unvested portion vests on that meeting date, subject to continued service.
- Timeliness: Form 4 filed within the required reporting window (filed June 1, 2026), so not late.
Context
This was a standard director compensation award (an option/derivative grant) rather than a market buy or sale. The award vests monthly over roughly one year (with an acceleration clause tied to the next annual meeting), so the shares/options are not immediately transferable — they vest over time and subject to continued service. Such grants are routine for non-employee directors and represent compensation, not an immediate signal to buy or sell stock.
Insider Transaction Report
- Award
Stock Option (Right to Buy)
[F1]2026-05-28+13,160→ 13,160 totalExercise: $32.68Exp: 2036-05-27→ Common Stock (13,160 underlying)
Footnotes (1)
- [F1]The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. 1/12th of the total number of shares of common stock subject to the option vest monthly following May 28, 2026, the date of grant. In the event the next occurring annual meeting of the Issuer's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service to the Issuer through each vesting date.